Financials
Financial year 2025
AB-INTERMED from Ukkel, company number BE0808382855, closed financial year 2025 with a result of € 86,058 after tax. For that financial year AB-INTERMED recorded a gross margin of € 107,426 and equity of € 330,581. Compared with financial year 2024, the result moved from € 94,927 to € 86,058. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 17, 2026.
€ 330,581
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 86,058
▼ 9% vs 2024
Profit after tax over the fiscal year.
€ 248,909
▼ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
46 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 3,170
▲ 5% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 610
Supplier invoices still open on the last day of the fiscal year.
€ 21,400
▼ 43% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 130,155 | € 162,405 | € 108,117 | € 107,426 | ▼ 1% |
| Profit after taxes | € 100,997 | € 133,208 | € 94,927 | € 86,058 | ▼ 9% |
| Equity | € 196,387 | € 259,595 | € 284,522 | € 330,581 | ▲ 16% |
| Total debts | € 96,538 | € 111,107 | € 83,639 | € 51,574 | ▼ 38% |
| Cash | € 211,293 | € 275,068 | € 257,260 | € 248,909 | ▼ 3% |
| Retained profit | € 177,787 | € 240,995 | € 265,922 | € 311,981 | ▲ 17% |
| Dividend | € 70,000 | € 70,000 | € 70,000 | € 40,000 | ▼ 43% |
| Bank debt | € 6,821 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 292,925 | € 370,702 | € 368,161 | € 382,155 | ▲ 4% |
Key figures of AB-INTERMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 1 February 2027.
Ask about AB-INTERMED the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to AB-INTERMED?
What happened at AB-INTERMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 86,058 (▼ 9% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- Assma BALLOUT became a director. NBB
In short
From € 100,997 profit in 2022 to € 86,058 profit in 2025.
Paid € 68,256 in corporate taxes since 2022.
Best year ever: 2023, with € 133,208 profit.
Paid out € 250,000 in dividends to the owners in total.
Management
Behind AB-INTERMED is Assma BALLOUT.
Directors
According to the 2025 annual accounts
Assma BALLOUT
Director
since 2008
Establishments
Establishment units
Physical locations of this company
Zonnebloemlaan 42
1180 Ukkel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Assma BALLOUT(oprichter) 100%
Details
- Company number
- 0808.382.855
- VAT number
- BE 0808.382.855
- Registered office
- Zonnebloemlaan 42, 1180 Ukkel
- Names & denominations
- AB-INTERMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 December 2008
- Peppol
- Active · Active since 10 Feb 2026